Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
-
J. Interferon Cytokine Res. · Oct 2020
ReviewImpact of Hydroxychloroquine/Chloroquine in COVID-19 Therapy: Two Sides of the Coin.
Coronavirus disease 2019 (COVID-19), which is caused by a novel severe acute respiratory syndrome coronavirus (SARS-CoV-2), has recently emerged as a global health threat. To address this health emergency, various therapeutic approaches are currently under investigation. ⋯ Based on several hospital findings, the Food and Drug Administration (FDA) has officially cancelled the emergency use authorization for HCQ and CQ for treating hospitalized COVID-19 patients on June 15, 2020. In this review, we highlight both pros and cons of the clinical use of CQ and HCQ in COVID-19 patients.